• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2020

View Archived Issues

Gracell begins study of GC-027 for relapsed or refractory T-cell malignancies

Read More

PERKing up astrocytes fights prion neurodegeneration

Read More

First-in-human data presented for BCMA-CD19 cCAR T-cells

Read More

Human CD83 CAR T cells for the prevention of GvHD and treatment of AML

Read More

Positive 6-month data from ongoing phase I/II study in X-linked retinitis pigmentosa

Read More

Regeneron announces phase II data for garetosmab in fibrodysplasia ossificans progressiva

Read More

Phase III CONSTANT trial of Sci-B-Vac meets primary and secondary endpoints

Read More

Locus begins phase Ib trial of CRISPR Cas3-enhanced bacteriophage product LBP-EC01

Read More

Novartis patents new compounds for leishmaniasis and trypanosomiasis

Read More

Dana-Farber Cancer Institute discloses new EGFR inhibitors

Read More

Aduro BioTech identifies cGAS inhibitors

Read More

Drexel University synthesizes new HIV capsid assembly inhibitors

Read More

Heptares Therapeutics discovers muscarinic M1 and/or M4 receptor agonists

Read More

Inhibrx initiates phase I study of hexavalent OX40 agonist INBRX-106 for solid tumors

Read More

Redx Pharma nominates ROCK2 inhibitor RXC-007 as drug development candidate in fibrosis

Read More

Biallelic loss-of-function variants in NADSYN1 cause congenital NAD deficiency and malformations

Read More

CBX-12 announced as Cybrexa Therapeutics' lead development program

Read More

Entrada announces development of ENTR-501 for mitochondrial neurogastrointestinal encephalomyopathy

Read More

Transgenic CD2-Lmo2/Ldb1 knockout mouse model of T-ALL

Read More

ELP5 found to be involved in gemcitabine sensitivity in gallbladder cancer

Read More

Sellas opens enrollment in phase III trial of galinpepimut-S for AML

Read More

Aclaris reports phase I data on oral MK2 inhibitor ATI-450

Read More

FDA approves Ayvakit for unresectable or metastatic PDGFRA exon 18 mutant GIST

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe